Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects.
- Published In:
- Pharmaceutics, 17(1) (2025)
- Authors:
- Lei, Yu, Liu, Jiacheng, Bai, Yaowei, Zheng, Chuansheng, Wang, Dongyuan
- Database ID:
- RPEP-12042
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12042APA
Lei, Yu; Liu, Jiacheng; Bai, Yaowei; Zheng, Chuansheng; Wang, Dongyuan. (2025). Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects.. Pharmaceutics, 17(1). https://doi.org/10.3390/pharmaceutics17010046
MLA
Lei, Yu, et al. "Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects.." Pharmaceutics, 2025. https://doi.org/10.3390/pharmaceutics17010046
RethinkPeptides
RethinkPeptides Research Database. "Peptides as Versatile Regulators in Cancer Immunotherapy: Re..." RPEP-12042. Retrieved from https://rethinkpeptides.com/research/lei-2025-peptides-as-versatile-regulators
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.